Swiss National Bank Omeros Corp Transaction History

Swiss National Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.92 - $6.28 $269,760 - $882,340	-140,500 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.07 - $7.2 $48,672 - $69,120	9,600 Added 7.33%	140,500 $844,000
Q3 2021 Nov 08, 2021	BUY	$13.4 - $16.3 $24,120 - $29,340	1,800 Added 1.39%	130,900 $1.81 Million
Q2 2021 Aug 06, 2021	BUY	$14.81 - $19.13 $34,063 - $43,999	2,300 Added 1.81%	129,100 $1.92 Million
Q1 2021 May 07, 2021	BUY	$14.52 - $23.53 $21,780 - $35,295	1,500 Added 1.2%	126,800 $2.26 Million
Q3 2020 Nov 09, 2020	BUY	$9.57 - $21.32 $166,518 - $370,968	17,400 Added 16.13%	125,300 $1.27 Million
Q2 2020 Aug 05, 2020	BUY	$12.21 - $16.99 $197,802 - $275,238	16,200 Added 17.67%	107,900 $1.59 Million
Q1 2020 May 08, 2020	BUY	$9.03 - $19.72 $18,963 - $41,412	2,100 Added 2.34%	91,700 $1.23 Million
Q4 2019 Feb 06, 2020	BUY	$13.01 - $17.15 $24,719 - $32,584	1,900 Added 2.17%	89,600 $1.26 Million
Q3 2019 Nov 12, 2019	BUY	$14.55 - $20.56 $14,550 - $20,560	1,000 Added 1.15%	87,700 $1.43 Million
Q2 2019 Aug 02, 2019	BUY	$15.0 - $19.62 $28,500 - $37,278	1,900 Added 2.24%	86,700 $1.36 Million
Q1 2019 May 10, 2019	BUY	$11.65 - $17.72 $37,280 - $56,704	3,200 Added 3.92%	84,800 $1.47 Million
Q4 2018 Feb 13, 2019	BUY	$10.72 - $16.73 $26,800 - $41,825	2,500 Added 3.16%	81,600 $909,000
Q1 2018 May 04, 2018	BUY	$9.0 - $20.16 $36,000 - $80,640	4,000 Added 5.33%	79,100 $884,000
Q3 2017 Nov 03, 2017	BUY	$19.76 - $24.9 $1.48 Million - $1.87 Million	75,100	75,100 $1.62 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $436M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.